Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1998-10-19
2000-12-19
Saunders, David
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241901, 4242001, 4242011, 4242031, 4242041, 4242461, 4242541, 4242571, 4242581, 4242611, 4242641, 4242651, 4242691, 4242701, 4242721, 435 693, 435 914, 4352523, 43525233, 4353201, A61K 3902, A61K 3908, A61K 39108, A61K 39112, C12N 120
Patent
active
061624330
ABSTRACT:
The invention relates to DNA constructs encoding a safe, selectable marker, other than an antibiotic resistance marker, vectors and/or cells including said constructs; and vaccines based on said constructs for use in animals and particularly humans. The safe, selectable marker being a marker that confers resistance to an agent, other than an antibiotic, which would otherwise deleteriously affect the growth of a cell in which said construct was placed.
REFERENCES:
Chabalgoity et al., "A Salmonella typhimurium htrA Live Vaccine Expressing Multiple Copies of a Peptide Comprising Amino Acids 8-23 of Herpes Simplex Virus Glycoprotein D as a Genetic Fusion to Tetanus Toxin Fragment C Protects Mice from Herpes Simplex Virus Infection," Molecular Microbiology, 19(4):791-801 (1996).
Chatfield et al., "Live Salomella as Vaccines and Carriers of Foreign Antigenic Determinants," Vaccine, 7:495-498 (Dec. 1989).
Chatfield et al, "Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single-Dose Oral Tetanus Vaccine," Bio/Technology, 10:888-892 (Aug. 1992).
D'Halluin et al., "The bar Gene as Selectable and Screenable Marker in Plant Engineering," Methods in Enzymology, 216:415-426 (1992).
Edwards et al., "Construction of .increment.aroA his .increment.pur Strains of Salmonella typhi," Journal of Bacteriology, 170(9):3991-3995 (Sep 1988).
Gonzalez et al., "Salmonella typhi Vaccine Strain CVD 908 Expressing the Circumsporozoite Protein of Plasmodium falciparum: Strain Construction and Safety and Immunogenicity in Humans," Journal of Infectious Diseases, 169:927-931 (1994).
Khan et al., "Construction, Expression, and Immunogenicity of the Schistosoma mansoni P28 Glutathione S-transferase as a Genetic Fusion to Tetanus Toxin Fragment C in a Live Aro Attenuated Vaccine Strain of Salmonella"Proc. Natl. Acad. Sci. USA, 91:11261-11265 (Nov. 1994).
Murakami et al., "The Bialaphos Biosynthetic Genes of Streptomyces hygroscopicus: Molecular Cloning and Characterization of the Gene Cluster," Molecular and General Genetics, 205:42-50 (1986).
Saiki et al., "Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase," Science, 239:487-491 (Jan. 1988).
Thompson et al., "Characterization of the Herbicide-resistance Gene bar from Streptomyces hygroscopicus," EMBO Journal, 6(9):2519-2523 (1987).
Tabor's CYclopedic Medical Dictionary. FA Davis Company, Philadelphia, p. A-140, 1984.
Somers, DA, et al. Fertile, transgenic oat plants. Biotechnology 10:1589-1594, 1992.
Fromm, M.E. Inheritance and expression of chiumeric genes in the progeny of transgenic maize plants. Biotechnology 8:833-839, 1990.
Olive, M, Ret al., The anaerobic responsive element contains two GC-rich sequences essential for binding a nuclear protein and hypoxic activation of the maize Adh1 promoter. Nucl. Acids Res. 19(25):7053-7060, 1991.
Hormaeche Carlos Estenio
Khan Mohammed Anjam
McNeill Hesta Varey
Medeva Europe Limited
Saunders David
Tung Mary B.
LandOfFree
Non antibiotic selectable markers for live vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non antibiotic selectable markers for live vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non antibiotic selectable markers for live vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-268935